José Antonio
Costoya Puente
Publicacións (66) Publicacións de José Antonio Costoya Puente
2024
-
AB067. New drug development for the use of PARP1-E2F1 transcriptional inhibitors in the treatment of glioblastoma
Chinese clinical oncology, Vol. 13, pp. AB067
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
2023
-
A New Opportunity for “Old” Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming
Cellular and Molecular Immunology
-
Inhibiting HER3 Hyperphosphorylation in HER2-Overexpressing Breast Cancer through Multimodal Therapy with Branched Gold Nanoshells
Small, Vol. 19, Núm. 50
2022
-
Development of a biosensor based on a new marine luciferase fused to an affibody to assess Her2 expression in living cells
Analytica Chimica Acta, Vol. 1221
-
Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration
International Journal of Pharmaceutics, Vol. 622
-
Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities
Frontiers in Oncology
-
New insights into the relevance of mobile DNA to cancer resistance in blind mole rats: new lessons for cancer therapy
Cellular and Molecular Immunology
2021
-
From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro
Journal of Cellular Physiology, Vol. 236, Núm. 11, pp. 7390-7404
-
SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19
Cellular and Molecular Immunology
2020
-
Immortalization of a cell line with neural stem cell characteristics derived from mouse embryo brain
Developmental Dynamics, Vol. 249, Núm. 1, pp. 112-124
-
Integración neuroendocrina
Fisiología humana (McGraw Hill Education México)
-
Parp1 deficiency reduces tumour growth by decreasing e2f1 hyperactivation: A novel mechanism in the treatment of cancer
Cancers, Vol. 12, Núm. 10, pp. 1-11
2019
-
A Bio-inspired Hypoxia Sensor using HIF1a-Oxygen-Dependent Degradation Domain
Scientific Reports, Vol. 9, Núm. 1
-
Expression of myostatin in human hematopoietic cells unveils novel autocrine/paracrine actions for the hormone
Journal of Cellular Physiology, Vol. 234, Núm. 5, pp. 7236-7246
2018
-
NK cell-based glioblastoma immunotherapy
Cancers, Vol. 10, Núm. 12
2017
2015
-
RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells
Cancer Cell International, Vol. 15, Núm. 1